MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Intraperitoneal Versus Extraperitoneal Colostomy
Phase 3
Completed
- Conditions
- Colostomy
- Interventions
- Procedure: intraperitoneal or extraperitoneal colostomy
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 81
- Registration Number
- NCT00964379
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
Completed
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2013-02-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00961948
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer
Phase 1
Completed
- Conditions
- Prostatic Neoplasm
- Interventions
- Radiation: radioimmuniguided intenstiy modulated radiotherapy
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2011-02-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 72
- Registration Number
- NCT00956228
- Locations
- 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States
Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT00955994
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Phase 1
Completed
- Conditions
- Primary Sclerosing CholangitisTrisomy 7CholangiocarcinomaChemoprevention
- Interventions
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT00955149
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Serum Procalcitonin
Completed
- Conditions
- Subarachnoid Hemorrhage (SAH)
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2011-06-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT00954551
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Novel Method of Surveillance in Barrett's Esophagus
Completed
- Conditions
- Barrett Esophagus
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2009-09-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 180
- Registration Number
- NCT00955019
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Is Plasma Transfusion Beneficial Prior to Low-Risk Procedures in Hospitalized Patients With Blood Clotting Abnormalities?
Phase 3
Completed
- Conditions
- Blood Coagulation, DisordersSurgical Procedures, Minimally Invasive
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-11-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 2
- Registration Number
- NCT00953901
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2012-02-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 1
- Registration Number
- NCT00953615
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
B-type Natriuretic Peptide (BNP) in Human Hypertension
Phase 1
Terminated
- Conditions
- Hypertension Stage 1
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2011-10-12
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 8
- Registration Number
- NCT00953472
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath